Song, J. (2018). A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationSong, J. A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationSong, J. A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy. The American Association for Cancer Research (AACR), 2018.
Warning: These citations may not always be 100% accurate.